International Patent: RECOMBINANT ADENOVIRUS VECTOR TUMOR VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF

GENEVA, June 26 -- BRITIE BIOTECH CO., LTD. filed a patent application (CN2025/139475) for “RECOMBINANT ADENOVIRUS VECTOR TUMOR VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF”. With publication no. WO/2026/119155, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....